Anti-Human IL17A Recombinant Antibody(Secukinumab)_天津卡梅德科技发展有限公司

>>

>>

>>

>

Anti-Human IL17A Recombinant Antibody(Secukinumab)

Anti-Human IL17A Recombinant Antibody(Secukinumab)

产品编号

YR1220

别名

科研级 Secukinumab ( 司库奴单抗 ), Anti-IL17A Recombinant Antibody, Research Grade Secukinumab

规格

1mg
5mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Alias	科研级 Secukinumab ( 司库奴单抗 ), Anti-IL17A Recombinant Antibody, Research Grade Secukinumab
Catalog Number	YR1220
Molecular Name	Secukinumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1 Kappa
Formulation	PBS, pH7.5
Background	Secukinumab, sold under the brand name Cosentyx, is a human IgG1κ monoclonal antibody that binds to the protein interleukin (IL)-17A, and is marketed by Novartis for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis. It inhibits a member of the cytokine family, interleukin 17A.
CAS Number	1229022-83-6
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Molecular Weight	147.94 kDa
Target	IL17A[Homo sapiens]

推荐产品

400-621-6806
614353794
周一至周五 9:00-18:00
0